Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$83.53
-0.4%
$84.49
$57.52
$113.28
$32.85B1.444.42 million shs1,573 shs
Masimo Corporation stock logo
MASI
Masimo
$154.49
-2.4%
$162.09
$101.61
$194.88
$8.37B1.19631,480 shs509,178 shs
Insulet Corporation stock logo
PODD
Insulet
$284.71
+0.4%
$309.07
$173.00
$329.33
$20.22B1.35714,927 shs349,138 shs
STERIS plc stock logo
STE
STERIS
$223.25
-0.6%
$238.70
$200.98
$252.79
$22.17B0.92562,249 shs1.72 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
0.00%+0.62%+4.86%+26.89%-24.87%
Masimo Corporation stock logo
MASI
Masimo
0.00%-5.23%-6.48%+3.50%+44.69%
Insulet Corporation stock logo
PODD
Insulet
0.00%-1.76%-6.24%+19.14%+45.74%
STERIS plc stock logo
STE
STERIS
0.00%-1.10%-4.27%+2.89%+0.50%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
DexCom, Inc. stock logo
DXCM
DexCom
4.7616 of 5 stars
3.53.00.04.73.32.51.9
Masimo Corporation stock logo
MASI
Masimo
4.2801 of 5 stars
2.43.00.04.23.13.31.3
Insulet Corporation stock logo
PODD
Insulet
4.6021 of 5 stars
3.43.00.04.93.20.81.9
STERIS plc stock logo
STE
STERIS
4.8416 of 5 stars
3.43.04.23.82.62.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DexCom, Inc. stock logo
DXCM
DexCom
2.91
Moderate Buy$99.6019.24% Upside
Masimo Corporation stock logo
MASI
Masimo
2.83
Moderate Buy$191.6024.02% Upside
Insulet Corporation stock logo
PODD
Insulet
2.83
Moderate Buy$321.0012.74% Upside
STERIS plc stock logo
STE
STERIS
2.75
Moderate Buy$266.5019.37% Upside

Current Analyst Ratings Breakdown

Latest MASI, DXCM, STE, and PODD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/16/2025
DexCom, Inc. stock logo
DXCM
DexCom
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$95.00 ➝ $100.00
7/15/2025
DexCom, Inc. stock logo
DXCM
DexCom
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$82.00 ➝ $89.00
7/15/2025
STERIS plc stock logo
STE
STERIS
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$260.00 ➝ $276.00
7/14/2025
Masimo Corporation stock logo
MASI
Masimo
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
7/8/2025
Insulet Corporation stock logo
PODD
Insulet
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
6/16/2025
DexCom, Inc. stock logo
DXCM
DexCom
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$102.00
6/16/2025
Insulet Corporation stock logo
PODD
Insulet
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$365.00
5/30/2025
DexCom, Inc. stock logo
DXCM
DexCom
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$104.00
5/30/2025
Insulet Corporation stock logo
PODD
Insulet
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$380.00
5/29/2025
STERIS plc stock logo
STE
STERIS
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold$263.00
5/27/2025
Insulet Corporation stock logo
PODD
Insulet
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$328.00 ➝ $360.00
(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DexCom, Inc. stock logo
DXCM
DexCom
$4.03B8.12$2.24 per share37.32$5.38 per share15.53
Masimo Corporation stock logo
MASI
Masimo
$2.09B4.00$6.39 per share24.18$19.50 per share7.92
Insulet Corporation stock logo
PODD
Insulet
$2.07B9.67$4.44 per share64.07$17.27 per share16.49
STERIS plc stock logo
STE
STERIS
$5.46B4.02$14.11 per share15.82$67.33 per share3.32
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DexCom, Inc. stock logo
DXCM
DexCom
$576.20M$1.3462.5133.951.7912.90%30.05%10.00%7/30/2025 (Estimated)
Masimo Corporation stock logo
MASI
Masimo
-$304.90M-$9.17N/A33.37N/A-25.06%22.56%10.00%8/5/2025 (Estimated)
Insulet Corporation stock logo
PODD
Insulet
$418.30M$5.5651.6657.292.5418.29%22.25%8.29%8/7/2025 (Confirmed)
STERIS plc stock logo
STE
STERIS
$614.64M$6.2036.3522.48N/A11.26%14.21%9.13%8/5/2025 (Estimated)

Latest MASI, DXCM, STE, and PODD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Insulet Corporation stock logo
PODD
Insulet
$0.9290N/AN/AN/A$612.31 millionN/A
8/5/2025Q2 2025
Masimo Corporation stock logo
MASI
Masimo
$1.23N/AN/AN/A$368.65 millionN/A
8/5/2025Q1 2026
STERIS plc stock logo
STE
STERIS
$2.32N/AN/AN/A$1.36 billionN/A
7/30/2025Q2 2025
DexCom, Inc. stock logo
DXCM
DexCom
$0.45N/AN/AN/A$1.13 billionN/A
5/14/2025Q4 2025
STERIS plc stock logo
STE
STERIS
$2.59$2.74+$0.15$1.47$1.47 billion$1.48 billion
5/8/2025Q1 2025
Insulet Corporation stock logo
PODD
Insulet
$0.81$1.02+$0.21$0.50$543.20 million$569.00 million
5/6/2025Q1 2025
Masimo Corporation stock logo
MASI
Masimo
$1.24$1.36+$0.12-$3.12$367.79 million$372.00 million
5/1/2025Q1 2025
DexCom, Inc. stock logo
DXCM
DexCom
$0.33$0.32-$0.01$0.27$1.02 billion$1.04 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
Masimo Corporation stock logo
MASI
Masimo
N/AN/AN/AN/AN/A
Insulet Corporation stock logo
PODD
Insulet
N/AN/AN/AN/AN/A
STERIS plc stock logo
STE
STERIS
$2.281.02%N/A36.77%20 Years

Latest MASI, DXCM, STE, and PODD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/7/2025
STERIS plc stock logo
STE
STERIS
quarterly$0.571.01%6/10/20256/10/20256/26/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DexCom, Inc. stock logo
DXCM
DexCom
0.55
1.50
1.32
Masimo Corporation stock logo
MASI
Masimo
0.67
2.17
1.62
Insulet Corporation stock logo
PODD
Insulet
1.21
4.47
3.63
STERIS plc stock logo
STE
STERIS
0.29
1.96
1.39

Institutional Ownership

CompanyInstitutional Ownership
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
Masimo Corporation stock logo
MASI
Masimo
85.96%
Insulet Corporation stock logo
PODD
Insulet
N/A
STERIS plc stock logo
STE
STERIS
94.69%

Insider Ownership

CompanyInsider Ownership
DexCom, Inc. stock logo
DXCM
DexCom
0.32%
Masimo Corporation stock logo
MASI
Masimo
16.90%
Insulet Corporation stock logo
PODD
Insulet
0.39%
STERIS plc stock logo
STE
STERIS
1.07%
CompanyEmployeesShares OutstandingFree FloatOptionable
DexCom, Inc. stock logo
DXCM
DexCom
10,300392.11 million390.85 millionOptionable
Masimo Corporation stock logo
MASI
Masimo
5,60054.22 million45.06 millionOptionable
Insulet Corporation stock logo
PODD
Insulet
3,90070.38 million70.10 millionOptionable
STERIS plc stock logo
STE
STERIS
17,78798.37 million97.32 millionOptionable

Recent News About These Companies

STERIS (NYSE:STE) Cut to "Buy" at Wall Street Zen
Equities Analysts Offer Predictions for STERIS Q2 Earnings
STERIS (NYSE:STE) Raised to Overweight at Morgan Stanley
Morgan Stanley Upgrades STERIS (STE)
Brokerages Set STERIS plc (NYSE:STE) Price Target at $263.83

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
DexCom stock logo

DexCom NASDAQ:DXCM

$83.53 -0.36 (-0.43%)
As of 09:42 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Masimo stock logo

Masimo NASDAQ:MASI

$154.49 -3.87 (-2.44%)
As of 09:42 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Insulet stock logo

Insulet NASDAQ:PODD

$284.71 +1.26 (+0.45%)
As of 09:42 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

STERIS stock logo

STERIS NYSE:STE

$223.25 -1.34 (-0.60%)
As of 09:42 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.